Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers
NCT ID: NCT02516540
Last Updated: 2024-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
600 participants
INTERVENTIONAL
2015-03-31
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Nutrition and Exercise Interventions in Women With Breast Cancer History
NCT07275957
Exercise and Nutrition Intervention in Ovarian Cancer
NCT06250686
Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors
NCT04200482
Impact of Home-based Aerobic and Strength Exercises During Chemotherapy for Early Breast Cancer on Biomarkers of Aging
NCT03761706
Studying Tailored Exercise Prescriptions in Breast Cancer Patients
NCT02802826
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Study participants are instructed regarding a healthy diet according to the recommendations of the German Nutrition Society (DGE) and are informed about positive effects of physical activity on incidence and prognosis of breast cancer
No interventions assigned to this group
Intervention
Structured exercise training plus mediterranean diet: Study participants receive a lifestyle intervention of 12 months duration (3 months intensive intervention plus 9 months maintenance using monthly contacts and meetings). The intervention comprises a structured intensified training based on the results of physical performance diagnostics and a nutrition program based on a mediterranean diet.
Structured exercise training plus mediterranean diet
Structured exercise training plus mediterranean diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Structured exercise training plus mediterranean diet
Structured exercise training plus mediterranean diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \>=18
* written informed consent
Exclusion Criteria
* metastatic tumor disease
* life expectancy \<3 years
* clinically limiting cardiovascular or respiratory disease (instable CVD, heart failure stage IV, COPD GOLD IV, maximum resting blood pressure 160/100 mmHg)
* significant orthopedic disability which prevents from participating in the group interventions
* severe concomitant diseases which prevents from participating in the group interventions
* Karnofsky index \<60
* maximum exercise capacity \<50 W
* food allergies which prevent from mediterranean diet
* vegan diet
* body mass index \<15 kg/m2
* pregnancy
* insufficient knowledge of German language
* insufficient compliance
* active participation in other interventional trials
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Hohenheim
OTHER
University Hospital Schleswig-Holstein
OTHER
University of Leipzig
OTHER
University of Cologne
OTHER
Technical University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marion Kiechle, Prof. Dr.
Role: STUDY_DIRECTOR
Technical University of Munich
Martin Halle, Prof. Dr.
Role: STUDY_DIRECTOR
Technical University of Munich
Stephan C Bischoff, Prof. Dr.
Role: STUDY_DIRECTOR
Universitaet Hohenheim, Stuttgart
Michael Siniatchkin, Prof. Dr.
Role: STUDY_DIRECTOR
University Hospital Schleswig-Holstein
Markus Loeffler, Prof. Dr.
Role: STUDY_DIRECTOR
University of Leipzig
Christoph Engel, PD Dr.
Role: STUDY_DIRECTOR
University of Leipzig
Rita K Schmutzler, Prof. Dr.
Role: STUDY_DIRECTOR
University of Cologne
Alfons Meindl, Prof. Dr.
Role: STUDY_DIRECTOR
Technical University of Munich
Anne S Quante, Dr.
Role: PRINCIPAL_INVESTIGATOR
Technical University of Munich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Humboldt Universität zu Berlin
Berlin, , Germany
Uniklinikum Köln
Cologne, , Germany
Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
Dresden, , Germany
Universitätsklinikum Düsseldorf
Düsseldorf, , Germany
Kliniken Essen-Mitte
Essen, , Germany
Universitätsklinikum Essen
Essen, , Germany
Universitätsklinikum Freiburg
Freiburg im Breisgau, , Germany
Universitätsmedizin Göttingen
Göttingen, , Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, , Germany
Medizinische Hochschule Hannover
Hanover, , Germany
Universitätsklinium Heidelberg
Heidelberg, , Germany
Universitätsklinikum Schleswig-Holstein, Campus Kiel
Kiel, , Germany
Universitätsklinikum Leipzig
Leipzig, , Germany
Technische Universität München
München, , Germany
Universität Regensburg
Regensburg, , Germany
Interdisziplinäres Brustzentrum am Diakonieklinikum
Stuttgart, , Germany
Universitätsklinikum Tübingen
Tübingen, , Germany
Universität Ulm
Ulm, , Germany
Universitätsklinikum Würzburg
Würzburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Seethaler B, Nguyen NK, Basrai M, Kiechle M, Walter J, Delzenne NM, Bischoff SC. Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity: data from the randomized controlled LIBRE trial. Am J Clin Nutr. 2022 Oct 6;116(4):928-942. doi: 10.1093/ajcn/nqac175.
Kiechle M, Engel C, Berling A, Hebestreit K, Bischoff SC, Dukatz R, Siniatchkin M, Pfeifer K, Grill S, Yahiaoui-Doktor M, Kirsch E, Niederberger U, Enders U, Loffler M, Meindl A, Rhiem K, Schmutzler R, Erickson N, Halle M. Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial. Trials. 2016 Jul 29;17:368. doi: 10.1186/s13063-016-1504-0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LIBRE-2-20150626
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.